Nan Ji (PAQ Therapeutics)

Dis­cov­ery by Shang­hai sci­en­tists in­spires new plan of AT­TEC for pro­tein degra­da­tion

In a re­view penned weeks ago, Craig Crews — the Yale sci­en­tist cred­it­ed with the dis­cov­ery of PRO­TACs — re­flect­ed on how, in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.